ArticleDiscover oncology2025

Disulfidptosis: a novel gene-based signature predicts prognosis and immunotherapy efficacy of pancreatic adenocarcinoma.

Jingyang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.